ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,166.76
0.03%
Dow Jones
39,169.52
0.13%
Gold vs US Dollar
2,333.98
0.07%
Brent Oil
86.685
0.18%
Bitcoin
62,951.19
0.16%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. CervoMed Inc (CRVO) Share Price

CRVO CervoMed Inc

16.12
-1.00 (-5.84%)
01 Jul 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 CervoMed Inc NASDAQ:CRVO NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -1.00 -5.84 16.12 14.87 17.63 17.23 15.40 17 45,832 21:16:11   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 7.15M -2.17M -0.2632 -16.72 36.32M
 Type  Size  Price  Time  Units 
 16 6,615 16.12 20:09:08 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore CRVO News
24/06/202413:00GLOBECervoMed Announces Addition to Russell 2000® and Russell 3000® Indexes
11/06/202413:00GLOBECervoMed Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies
20/05/202413:00GLOBECervoMed to Appoint William Elder as Chief Financial Officer
15/05/202413:00GLOBECervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates
01/04/202413:00GLOBECervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
28/03/202412:30GLOBECervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
05/03/202413:00GLOBECervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024
Period
Draw mode
Data Downloads for CRVO

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest CervoMed Inc Articles